Elliott Investment Management L.P. and Elliott Advisors (UK) Limited ("Elliott"), which advise funds that together have a significant investment in Mitsui ...
Kolibri Global Energy Inc. (the "Company" or "KGEI") (TSX: KEI, NASDAQ: KGEI) is providing the results of its December 31, 2025, independent reserves evaluation. All amounts are in US$ unless otherwis ...
Nexus Uranium Corp. (CSE: NEXU) (OTCQB: NEXUF) (FSE: JA7) ("Nexus" or the "Company") announces the establishment of an at-the-market ...
A recent value retention rate report for February released by the China Automobile Dealers Association shows that GAC continues to lead among ...
Duos Technologies Group, Inc. ("Duos" or the "Company") (Nasdaq: DUOT), through its operating subsidiaries including Duos ...
High-throughput, mid capacity LH210 expands the VISQUE DPS lineup with fast scanning, optimized data size, and scalable digital pathology workflowANYANG, South Korea, March 18, 2026 /PRNewswire/ ...
New clinical data from Phase 1 trial of ZW191 to be presented in an oral presentation on April 21Preclinical data highlight combination potential for ZW191, a folate receptor alpha (FR?)-targeting ant ...
MPVDTORONTO and NEW YORK, March 17, 2026 /PRNewswire/ -- Mountain Province Diamonds Inc. ("Mountain Province" or the "Company") (TSX: MPVD) (OTC: MPVD) announces today that the ...
Carrier Global Corporation (NYSE: CARR), global leader in intelligent climate and energy solutions, today announced that its venture ...
Two abstracts accepted for presentationOne abstract on new additional biomarker and immunogenicity data for personalized cancer vaccine EVX-01Another abstract on the use of Evaxion's AI-Immunology pla ...
A company belonging to the Nordecon AS group, Swencn AB, entered into a contract in August 2018 for the construction of a residential development project in the Stockholm region (announcement). Due to ...
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., March 17, 2026 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of custo ...